Alvogen

Alvogen Loses FDA Battle for Xifaxan Generic

Court Rejects Alvogenโ€™s Push for FDA Nod on Bausch’s Xifaxan Generic

Anika Sharma

Salix Pharmaceuticals, the gastroenterology division of Bausch Health, has successfully defended its irritable bowel syndrome diarrhea medication, Xifaxan, against a ...